Incannex Healthcare Limited
IXHL | NASDAQ
$3.57
-$0.07 (-1.92%)
Sep 21, 2026, 10:31 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Jun 29, 2025 | FY 2024 Jun 29, 2024 | FY 2023 Jun 29, 2023 | FY 2022 Jun 29, 2022 | FY 2021 Jun 29, 2021 | FY 2020 Jun 29, 2020 |
|---|---|---|---|---|---|---|
Revenue | 86K | 12K | n/a | 785.15K | 1.9M | 599.72K |
Cost of Revenue | 246K | 103K | n/a | 6.34K | 913.26K | 446.5K |
Gross Profit | -160K | 12K | n/a | 778.79K | 987.02K | 153.22K |
Operating Income | -23.79M | -30.04M | -20.53M | -10.16M | -11.43M | -4.11M |
Interest Income | 62K | 308.4K | 362.73K | 6.27K | 2.68K | 4.5K |
Pretax Income | -48.64M | -18.43M | -73.47M | -10.25M | -11.39M | -3.9M |
Net Income | -46.89M | -18.46M | -73.47M | -14.9M | -11.39M | -4.66M |
Selling & General & Admin | 13.13M | 25.56M | 11.93M | 10.18M | 7.7M | 2.17M |
Research & Development | 10.75M | 19.28M | 9.5M | 5.37M | 4.76M | n/a |
Other Expenses | -246K | -14.79M | -895.54K | -3.38M | -37.55K | 2.09M |
Operating Expenses | 23.63M | 30.05M | 20.53M | 12.17M | 12.41M | 4.26M |
Interest Expense | 303K | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 390K | 1.58M | 1.88M | 2.75M | 4.35M | 402.76K |
Cost & Expenses | 23.88M | 30.05M | 20.53M | 12.18M | 13.33M | 4.71M |
Income Tax Expense | -1.76M | 30K | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.15M | 5.39M | 5.13M | 9.93M | 8.15M | 5.7M |
Shares Outstanding (Diluted) | 1.15M | 5.39M | 5.13M | 9.93M | 8.15M | 5.7M |
EPS (Basic) | -40.80 | -3.42 | -14.31 | -1.51 | -1.40 | -0.69 |
EPS (Diluted) | -40.80 | -3.42 | -14.31 | -1.51 | -1.40 | -0.69 |
EBITDA | -23.54M | -27.7M | -20.39M | -16.54M | -11.43M | -4.06M |
EBIT | -23.79M | -27.86M | -20.53M | -16.54M | -11.43M | -4.11M |
Depreciation & Amortization | 246K | 154.2K | 132.45K | n/a | n/a | 52.73K |
Add to Watchlist
Select watchlists to add or remove IXHL